PET brain scans to diagnose Alzheimer's
Part of Brain & nervous system, Mental health clinical trials.
This study uses special brain scans (PET scans) to look for proteins linked to Alzheimer's disease. It aims to improve diagnosis and track how the disease progresses over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You have either mild cognitive impairment or diagnosed Alzheimer's disease, with symptoms like memory problems and trouble concentrating.
- You have had blood or spinal fluid tests showing higher levels of Alzheimer's-related proteins.
- You are able to have a PET scan (which involves an injection of a tracer).
- You do not have other major medical conditions like heart disease, cancer, or a history of seizures or head injury.
- You are not pregnant, breastfeeding, or allergic to contrast agents.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of brain scan ([18F]F-AraG PET) that may help detect Alzheimer's disease earlier or more accurately. Researchers will take pictures of your brain to see if this scan can identify changes related to Alzheimer's.
This trial uses special PET scans to see amyloid and tau proteins in the brain, which are linked to Alzheimer's. It aims to find these changes early, in people with mild memory problems or early-stage Alzheimer's.
This trial uses a new type of PET scan to look for specific proteins in the brain that are linked to Alzheimer's disease. It will help doctors see how these proteins relate to cognitive decline and compare scans from people with normal thinking to those with memory problems.
This study uses a special PET brain scan to look at two types of brain immune cells in people with Alzheimer’s. It may help researchers better understand Alzheimer’s and how these cells change over time.
This study uses a special PET scan to take pictures of abnormal tau protein in the brain. It aims to see if the scan results match what is found in brain tissue after death, which could help improve diagnosis of Alzheimer's and related conditions.
This study uses a special PET scan to look at a brain protein called PDE4 in people with Alzheimer's disease or mild cognitive impairment. It may help researchers understand how this protein is involved in memory and thinking problems.
Hear when a new Cognitive Dysfunction, Cognitive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.